机译:接枝中的CD45RA +调节性T细胞(Tregs)与供体年龄的反向相关,并影响患者患者患者患者患者的早期含量和生存率与移植后环磷酰胺(PTCY)
Blood and Marrow Transplantation and Hematology Dharamshila Narayana Hospital and Research Centre;
Blood and Marrow Transplantation and Hematology Dharamshila Narayana Hospital and Research Centre;
Blood and Marrow Transplantation and Hematology Dharamshila Narayana Hospital and Research Centre;
Blood and Marrow Transplantation and Hematology Dharamshila Narayana Hospital and Research Centre;
Manashi Chakrabarti Foundation;
Blood and Marrow Transplantation and Hematology Dharamshila Narayana Hospital and Research Centre;
Blood and Marrow Transplantation and Hematology Dharamshila Narayana Hospital and Research Centre;
机译:接枝中的CD45RA +调节性T细胞(Tregs)与供体年龄的反向相关,并影响患者患者患者患者患者的早期含量和生存率与移植后环磷酰胺(PTCY)
机译:接枝中的CD45RA +调节性T细胞(Tregs)与供体年龄的反向相关,并影响患者患者患者患者患者的早期含量和生存率与移植后环磷酰胺(PTCY)
机译:None
机译:抗HLA抗体患者接枝衰竭的高风险,抗HLA抗体患者进行了寄生干细胞移植
机译:使用移植后环磷酰胺预防单倍体供体和不匹配的无关供体造血干细胞移植的移植物抗宿主病的2臂2期临床试验的结果
机译:移植后基于环磷酰胺的肝脏,基于血液恶性肿瘤患者的患者基于环磷酰胺的寄生,基于患者的患者的无关助力患者患者:209名患者的单中心经验